Bipolar Disorders: Mixed States, Rapid-Cycling, and Atypical Forms

321 Rapid cycling and mixed statesJoffe, R. T., Young, L. T., Cooke, R. G., and Robb, J. (1994). The thyroid and mixed affectivestates. Acta Psychiatr. Scand, 90, 131–2.Juckel, G., Hegerl, U., Mavrogiorgou, P., et al. (2000). Clinical and biological findings in a casewith 48-hour bipolar ultrarapid cycling before and during valproate treatment. J. Clin.Psychiatry, 61, 585–93.Kato, T., Murashita, J., Kamiya, A., et al. (1998). Decreased brain intracellular pH measuredby 31 P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation withwhite matter hyperintensity. Eur. Arch. Psychiatry Clin. Neurosci., 248, 301–6.Keck,P.E.,Versiani,M.,Potkin,S.et al. (2003). Ziprasidone in the treatment of acute bipolar mania:a three-week, placebo-centrolled, double-blind, randomized trial. Am.J.Psychiatry, 160, 741–8.Kelsoe, J. R., Sadovnick, A. D., Kristbjarnarson, H., et al. (1996). Possible locus for bipolardisorder near the dopamine transporter on chromosome 5. Am. J. Med. Genet., 67, 533–40.Kilzieh, N. and Akiskal, H. S. (1999). Rapid-cycling bipolar disorder. An overview of researchand clinical experience. Psychiatr. Clin. North Am., 22, 585–607.Krishnan,R.R.,Maltbie,A.A.,andDavidson,J.R.(1983).Abnormalcortisolsuppressioninbipolarpatients with simultaneous manic and depressive symptoms. Am.J.Psychiatry, 140, 203–5.Kupka, R. W., Nolen, W. A., Post, R. M. et al. (2002). High rate of autoimmune thyroiditis inbipolar disorder: lack of association with lithium exposure. Biol. Psychiatry, 51, 305–11.Lenox, R. H. and Watson, D. G. (1994). Lithium and the brain: a psychopharmacologicalstrategy to a molecular basis for manic depressive illness. Clin. Chem., 40, 309–14.Lisman, J. (1994). The CaM kinase II hypothesis for the storage of synaptic memory. TrendsNeurosci., 17, 406–12.Maes, M., Calabrese, J., Jayathilake, K., and Meltzer, H. Y. (1997). Effects of subchronic treatmentwith valproate on L-5-HTP-induced cortisol responses in mania: evidence for increasedcentral serotonergic neurotransmission. Psychiatry Res., 71, 67–76.Manji, H. K. and Potter, W. Z. (1997). Monoaminergic system. In Bipolar Disorder–BiologicalModels and their Clinical Application, ed. L. T. Young and R. T. Joffe, pp. 1–40. New York:Marcel Dekker.Manki, H., Kanba, S., Muramatsu, T., et al. (1996). Dopamine D 2 ,D 3 and D 4 receptor andtransporter gene polymorphisms and mood disorders. J. Affect. Disord., 40, 7–13.Massat, I., Souery, D., Del Favero, J., et al. (2002). Positive association of dopamine D 2 receptorpolymorphism with bipolar affective disorder in a European Multicenter Association Study ofaffective disorders. Am. J. Med. Genet., 114, 177.McElroy, S. L., Keck, P. E., Pope, H. G., et al. (1992). Clinical and research implications of thediagnosis of dysphoric or mixed mania or hypomania. Am. J. Psychiatry, 149, 1633–44.McElroy, S. L., Freeman, M. P., and Akiskal, H. S., (2000). The mixed bipolar disorders.In Bipolar Disorders–100 Years after Manic Depressive Insanity, ed. A. Marneros, andJ. Angst, pp. 63–88. Dordrecht: Kluwer Academic Publishers.Meltzer, H. L. (1986). Lithium mechanisms in bipolar illness and altered intracellular calciumfunctions. Biol. Psychiatry, 21, 492–510.Meltzer, H. Y., and Lowy, M. T. (1987). The serotonin hypothesis of depression.In Psychopharmacology: The Third Generation of Progress, ed. H. Y. Meltzer, pp. 513–26.New York: Raven Press.